The effect of valproic acid on sister chromatid exchange aberration frequency in epileptic children
Insights
Valproic acid (VPA) significantly increases sister chromatid exchange (SCE) in children, indicating potential DNA damage. This effect was observed in children on VPA therapy and in vitro, suggesting VPA is the cause, not epilepsy.
Area of Science:
- Genetics
- Pediatrics
- Pharmacology
Background:
- Epilepsy is a common neurological disorder in children.
- Valproic acid (VPA) is a widely used antiepileptic drug.
- Assessing the genotoxicity of VPA in pediatric patients is crucial.
Purpose of the Study:
- To investigate the genotoxic effects of valproic acid (VPA) in epileptic children.
- To evaluate the impact of VPA on sister chromatid exchange (SCE) and chromosome aberrations.
Main Methods:
- Peripheral lymphocytes from epileptic children on VPA monotherapy and control groups were analyzed for SCE and chromosome aberrations.
- SCE was assessed in children before and after VPA treatment.
- In vitro exposure of normal lymphocytes to sodium valproate was performed.
Main Results:
- A significant increase in SCE frequency was observed in children treated with VPA compared to controls.
- SCE levels showed a statistically significant change after VPA intake in epileptic children.
- In vitro exposure to sodium valproate also resulted in a significant increase in SCE.
Conclusions:
- Valproic acid (VPA) and its derivatives demonstrate genotoxic potential, evidenced by increased SCE in child users.
- The observed increase in SCE is likely attributable to VPA, independent of epilepsy.
- While chromosome aberration rates were slightly elevated, they were not statistically significant compared to controls.
Abstract:
Sister chromatid exchange (SCE) and chromosome aberration have been used to examine the peripheral lymphocytes of 20 epileptic children on 6-52 months monotherapy with valproic acid (VPA), and two matched control groups were set for comparison. The frequency of SCE in the VPA treated group is significantly higher than two control groups (P less than 0.01). It seems that the increase in SCE frequency is not related to epilepsy. SCE was also examined in 10 epileptic children before and after intake of only sodium valroat for 6-7 months, there was statistically significant change of SCE following VPA. 9 normal children's lymphocytes were exposed in vitro to sodium valproate (5-20 micrograms/ml), all showed a significant increase in SCE. These results suggested that VPA and its derivatives could damage the DNA of child users; however slightly higher rates of chromosome aberration were not significantly different from two control groups.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...